cilengitide has been researched along with Cancer of Skin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, G; Jin, Y; Liu, B; Liu, C; Pan, X; Yi, M; Yuan, X | 1 |
| Im, H; Lee, J; Ryu, KY; Yi, JY | 1 |
| Bedikian, AY; Camacho, LH; Colevas, AD; Diwan, AH; Gallick, GE; Hwu, P; Johnson, MM; Joseph, RW; Kim, KB; Ng, CS; Papadopoulos, NE; Prieto, V; Reckeweg, A; Vardeleon, A; Wei, W; Wittemer, SM | 1 |
| Tucker, GC | 1 |
| Cheresh, DA; Laug, WE; MacDonald, TJ; Shimada, H; Tabrizi, P; Taga, T; Zlokovic, BV | 1 |
1 review(s) available for cilengitide and Cancer of Skin
| Article | Year |
|---|---|
Integrins: molecular targets in cancer therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biomarkers, Tumor; Central Nervous System Neoplasms; Clinical Trials as Topic; Glioblastoma; Humans; Indoles; Integrins; Melanoma; Neoplasms; Porphyrins; Skin Neoplasms; Snake Venoms; Sulfonamides | 2006 |
1 trial(s) available for cilengitide and Cancer of Skin
| Article | Year |
|---|---|
A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Snake Venoms | 2012 |
3 other study(ies) available for cilengitide and Cancer of Skin
| Article | Year |
|---|---|
Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model.
Topics: Animals; Apoptosis; B7-H1 Antigen; Cell Survival; Female; Immunohistochemistry; Integrin alphaVbeta3; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Skin Neoplasms; Snake Venoms | 2022 |
Integrin αvβ3-Akt signalling plays a role in radioresistance of melanoma.
Topics: Cell Line, Tumor; Cell Survival; Gamma Rays; Heterocyclic Compounds, 3-Ring; Humans; Integrin alphaVbeta3; Melanoma; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Signal Transduction; Skin Neoplasms; Snake Venoms | 2020 |
Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist.
Topics: Allantois; Angiogenesis Inhibitors; Animals; Blood Vessels; Brain Neoplasms; Chick Embryo; Chorion; Drug Resistance; Humans; Integrins; Mice; Mice, Nude; Neoplasm Transplantation; Peptides, Cyclic; Skin Neoplasms; Snake Venoms; Transplantation, Heterologous | 2001 |